Top

BMC Nephrology

Published in:

Open Access 01-12-2015 | Research article

Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

Authors: Ciou-Sia Dai, Chen-Chung Chu, Shin-Fan Chen, Chiao-Yin Sun, Marie Lin, Chin-Chan Lee

Published in: BMC Nephrology | Issue 1/2015

Abstract

Background

End stage renal disease (ESRD) is prevalent in Taiwan. Human leukocyte antigens (HLA) have been found to be associated with the pathogenesis of autoimmune diseases, allergies and inflammatory bowel diseases, and there are emerging evidences of correlations between HLA genotypes and renal diseases such as diabetic nephropathy, IgA nephropathy, and glomerulonephritis. The aim of this study is to investigate detailed HLA subtypes in a case-control study of Taiwanese individuals.

Methods

The polymorphisms of HLA class I and II antigens in ESRD patients and a healthy control group were retrospectively analyzed. The information of 141 ESRD patients was obtained from the medical record of the Keelung branch of Chang Gung Memorial Hospital and was compared to the HLA type of a control group comprized of 190 healthy unrelated Taiwanese from one of our previous studies. In order to standardize the HLA designation of prior low-resolution typings with the more advanced DNA based typings, all HLA-A, −B and -DR were analyzed using a low resolution serologic equivalent.

Results

The current work suggests that HLA-DR3 (odds ratio = 1.91, 95 % CI = 1.098–3.324, P = 0.024, Pc = 0.312) and HLA-DR11 (odds ratio = 2.06, 95 % CI = 1.133–3.761, P = 0.021, Pc = 0.273) may represent susceptibility risk factors for the development of ESRD in Taiwanese individuals. On the other hand, HLA-DR8 (odds ratio = 0.47, 95 % CI = 0.236–0.920, p = 0.027. Pc = 0.351) may be a protective factor. HLA-A and -B antigens did not show any contribution of progression to ESRD. However, we note that the significance of all these findings is lost when the results are corrected for multiple comparisons according to Bonferroni. Further investigation with a larger group of patients and control is needed to resolve this issue.

Conclusions

HLA typing might be a useful clinical method for screening patients with high risk of progression to ESRD.

Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis : Off J National Kidney Foundation. 2007;49(1):46–55.CrossRef

Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology. 2010;15 Suppl 2:3–9.PubMedCrossRef

Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Hung MJ, et al. Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels—a four-years prospective cohort study in Taiwan. BMC Nephrol. 2013;14.

Qaseem A, Hopkins Jr RH, Sweet DE, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159(12):835–47.PubMed

Parham P, Ohta T. Population biology of antigen presentation by MHC class I molecules. Science. 1996;272(5258):67–74.PubMedCrossRef

Marsh SG, System WHONCfFotH. Nomenclature for factors of the HLA system, update April 2010. Tissue Antigens. 2010;76(6):501–8.PubMedCrossRef

Lange CF. HL-A histocompatibility antigens and their relation to disease. Prog Clin Pathol. 1975;6:137–62.PubMed

Tsao BP. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep. 2002;4(4):359–67.PubMedCrossRef

Phillips EJ, Mallal SA. HLA and drug-induced toxicity. Curr Opin Mol Ther. 2009;11(3):231–42.PubMed

10.

Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci. 2012;19:88.PubMedPubMedCentralCrossRef

11.

van der Gaag R, Luyendijk L, Linssen A, Kijlstra A. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis. Clin Exp Immunol. 1985;60(2):311–5.PubMedPubMedCentral

12.

Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. WJG. 2006;12(23):3628–35.PubMedPubMedCentralCrossRef

13.

Kallaur AP, Kaimen-Maciel DR, Morimoto HK, Watanabe MA, Georgeto SM, Reiche EM. Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). Int J Mol Med. 2011;28(4):467–79.PubMed

14.

Kohara M, Naito S, Arakawa K, Miyata J, Chihara J, Taguchi T, et al. The strong association of HLA-DR4 with spherical mesangial dense deposits in IgA nephropathy. J Clin Lab Immunol. 1985;18(4):157–60.PubMed

15.

Dyck R, Bohm C, Klomp H. Increased frequency of HLA A2/DR4 and A2/DR8 haplotypes in young saskatchewan aboriginal people with diabetic end-stage renal disease. Am J Nephrol. 2003;23(3):178–85.PubMedCrossRef

16.

Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Lundstrom E, Fernstrom A, et al. Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population. Hum Immunol. 2013;74(8):957–60.PubMedCrossRef

17.

Hsieh NK, Chu CC, Lee NS, Lee HL, Lin M. Association of HLA-DRB1*0405 with resistance to multibacillary leprosy in Taiwanese. Hum Immunol. 2010;71(7):712–6.PubMedCrossRef

18.

Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens. 1999;53(1):51–64.PubMedCrossRef

19.

Lin M, Chu CC, Chang SL, Lee HL, Loo JH, Akaza T, et al. The origin of Minnan and Hakka, the so-called “Taiwanese”, inferred by HLA study. Tissue Antigens. 2001;57(3):192–9.PubMedCrossRef

20.

Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH, et al. The HLA dictionary 2008: a summary of HLA-A, −B, −C, −DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, −B, −C, −DR, and -DQ antigens. Tissue Antigens. 2009;73(2):95–170.PubMedCrossRef

21.

van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant: Off Pub Euro Dialysis Transplant Assoc - European Renal Assoc. 2001;16(6):1120–9.CrossRef

22.

Cao Q, Xie D, Liu J, Zou H, Zhang Y, Zhang H, et al. HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation. PLoS One. 2014;9(6), e90869.PubMedPubMedCentralCrossRef

23.

Rees AJ, Peters DK, Amos N, Welsh KI, Batchelor JR. The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int. 1984;26(4):445–50.PubMedCrossRef

24.

Watts GF, Taub N, Gant V, Wilson I, Shaw KM. The immunogenetics of early nephropathy in insulin-dependent diabetes mellitus: association between the HLA-A2 antigen and albuminuria. Q J Med. 1992;83(302):461–71.PubMed

25.

Gerbase-DeLima M, Pereira-Santos A, Sesso R, Temin J, Aragao ES, Ajzen H, et al. Idiopathic focal segmental glomerulosclerosis and HLA antigens. Braz J Med Biol Res. 1998;31(3):387–9.PubMedCrossRef

26.

Marchini M, Antonioli R, Lleo A, Barili M, Caronni M, Origgi L, et al. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol. 2003;64(4):462–8.PubMedCrossRef

27.

Park MH, Song EY, Ahn C, Oh KH, Yang J, Kang SJ, et al. Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans. Tissue Antigens. 2003;62(6):505–11.PubMedCrossRef

28.

Vaglio A, Martorana D, Maggiore U, Grasselli C, Zanetti A, Pesci A, et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 2007;56(9):3159–66.PubMedCrossRef

29.

Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, et al. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes. 2008;57(2):518–22.PubMedCrossRef

30.

Karahan GE, Seyhun Y, Oguz FS, Kekik C, Onal AE, Yazici H, et al. Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease. Ren Fail. 2009;31(1):44–9.PubMedCrossRef

31.

Pan CF, Wu CJ, Chen HH, Dang CW, Chang FM, Liu HF, et al. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus. 2009;18(8):698–704.PubMedCrossRef

32.

Yang R, Cui Z, Zhao J, Zhao MH. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol. 2009;133(2):245–50.PubMedCrossRef

33.

Chang DY, Luo H, Zhou XJ, Chen M, Zhao MH. Association of HLA genes with clinical outcomes of ANCA-associated vasculitis. CJASN. 2012;7(8):1293–9.PubMedPubMedCentralCrossRef

34.

Perez-Luque E, Malacara JM, Olivo-Diaz A, Alaez C, Debaz H, Vazquez-Garcia M, et al. Contribution of HLA class II genes to end stage renal disease in mexican patients with type 2 diabetes mellitus. Hum Immunol. 2000;61(10):1031–8.PubMedCrossRef

35.

El-Gezawy EM, Baset HA, Nasif KA, Osama A, AbdelAzeem HG, Ali M, et al. Human leukocyte antigens as a risk factor for the primary diseases leading to end stage renal disease in Egyptian patients. Egypt J Immunol/ Egyptian Asso Immunologists. 2011;18(2):13–21.

36.

Doxiadis II, De Lange P, De Vries E, Persijn GG, Claas FH. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure. Tissue Antigens. 2001;57(4):344–7.PubMedCrossRef

37.

Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens. 1992;40(2):90–7.PubMedCrossRef

38.

Chou HT, Chen CH, Chen JY, Chang KC. Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int J Cardiol. 2008;128(3):434–5.PubMedCrossRef

39.

Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis. 2002;186(11):1565–74.PubMedCrossRef

40.

Yang J, Qiao HL, Zhang YW, Jia LJ, Tian X, Gao N. HLA-DRB genotype and specific IgE responses in patients with allergies to penicillins. Chin Med J. 2006;119(6):458–66.PubMed

41.

Hiki Y, Kobayashi Y, Tateno S, Sada M, Kashiwagi N. Strong association of HLA-DR4 with benign IgA nephropathy. Nephron. 1982;32(3):222–6.PubMedCrossRef

42.

Mosaad YM, Mansour M, Al-Muzairai I, Al-Otabi T, Abdul-Moneam M, Al-Attiyah R, et al. Association between Human Leukocyte Antigens (HLA-A, −B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation. Ren Fail. 2014;36(8):1317–21.PubMedCrossRef

43.

Almogren A, Shakoor Z, Hamam KD. Human leucocyte antigens: their association with end-stage renal disease in Saudi patients awaiting transplantation. Br J Biomed Sci. 2012;69(4):159–63.PubMed

44.

Freedman BI, Spray BJ, Heise ER. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis : Off J National Kidney Foundation. 1994;23(3):352–7.CrossRef

45.

Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis: Off J National Kidney Foundation. 1991;18(1):12–9.CrossRef

46.

Berthoux FC, Genin C, Gagne A, Le Petit JC, Sabatier JC. HLA Bw35 antigen and mesangial IgA glomerulo-nephritis: a poor prognosis marker? Proc Euro Dialysis Transplant Assoc European Dialysis Transplant Assoc. 1979;16:551–5.

47.

Cao HX, Li M, Nie J, Wang W, Zhou SF, Yu XQ. Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese. Am J Nephrol. 2008;28(4):684–91.PubMedPubMedCentralCrossRef

48.

Raguenes O, Mercier B, Cledes J, Whebe B, Ferec C. HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome. Tissue Antigens. 1995;45(4):246–9.PubMedCrossRef

49.

Hiki Y, Kobayashi Y, Ookubo M, Obata F, Kashiwagi N. Association of HLA-DQw4 with IgA nephropathy in the Japanese population. Nephron. 1991;58(1):109–11.PubMedCrossRef

50.

Chevrier D, Giral M, Perrichot R, Latinne D, Coville P, Muller JY, et al. Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci. Tissue Antigens. 1997;50(2):164–9.PubMedCrossRef

51.

Huang CC. Strong association of HLA-DR3 in Chinese patients with idiopathic membranous nephropathy. Tissue Antigens. 1989;33(3):425–6.PubMedCrossRef

52.

Freedman BI, Spray BJ, Dunston GM, Heise ER. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation. Am J Kidney Dis : Off J National Kidney Foundation. 1994;23(6):797–802.CrossRef

53.

Reichert LJ, Koene RA, Wetzels JF. Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis: Off J National Kidney Foundation. 1998;31(1):1–11.CrossRef

54.

Bhimma R, Hammond MG, Coovadia HM, Adhikari M, Connolly CA. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int. 2002;61(4):1510–5.PubMedCrossRef

55.

Haskell LP, Glicklich D, Senitzer D. HLA associations in heroin-associated nephropathy. Am J Kidney Dis: Off J National Kidney Foundation. 1988;12(1):45–50.CrossRef

56.

Freedman BI, Espeland MA, Heise ER, Adams PL, Buckalew Jr VM, Canzanello VJ. Racial differences in HLA antigen frequency and hypertensive renal failure. Am J Hypertens. 1991;4(5 Pt 1):393–8.PubMedCrossRef

Title: Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study
Authors: Ciou-Sia Dai
Chen-Chung Chu
Shin-Fan Chen
Chiao-Yin Sun
Marie Lin
Chin-Chan Lee
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-015-0165-7

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study

Exaggerated blood pressure response to dynamic exercise despite chronic refractory hypotension: results of a human case study

TWEAK/Fn14 system and crescent formation in IgA nephropathy

Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease

A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis

Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page